Literature DB >> 19147583

Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.

Kathy Hormi-Carver1, Xi Zhang, Hui Ying Zhang, Robert H Whitehead, Lance S Terada, Stuart J Spechler, Rhonda F Souza.   

Abstract

Apoptosis is an important mechanism for maintaining tissue homeostasis and for preventing the proliferation of cells with mutations that could result in malignancy. Barrett's epithelium has been reported to be more resistant to apoptosis than normal esophageal squamous epithelium. We have explored the contribution of the nuclear factor-kappaB (NF-kappaB) pathway to apoptotic resistance in non-neoplastic, telomerase-immortalized esophageal squamous (NES) and Barrett's (BAR-T) epithelial cell lines. We exposed these cells to UV-B irradiation in doses known to cause DNA damage and to induce apoptosis in normal cells, and studied apoptosis as well as the expression of phospho-H2AX, NF-kappaB, Bcl-2, XIAP, cIAP-1, and survivin proteins. We also used Bay 11-7085 and siRNAs to NF-kappaB and Bcl-2 to assess the effects of NF-kappaB and Bcl2 inhibition on apoptosis. UV-B irradiation at low doses (50 and 100 J/m(2)) caused DNA damage in both NES and BAR-T cells but significantly increased apoptosis only in NES cells. UV-B irradiation caused a decrease in the levels of NF-kappaB, Bcl-2, cIAP-1, XIAP, and survivin in NES cells but increased the levels of those proteins in BAR-T cells. The resistance of BAR-T cells to apoptosis induced by low-dose UV-B irradiation was abolished by Bay 11-7085 and by siRNA for NF-kappaB and was decreased significantly by siRNA for Bcl-2. We conclude that the ability of Barrett's epithelial cells to activate the NF-kappaB pathway when they have sustained DNA damage allows them to resist apoptosis. This capacity to avoid apoptosis despite genotoxic damage may underlie the persistence and malignant predisposition of Barrett's metaplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147583      PMCID: PMC2629390          DOI: 10.1158/0008-5472.CAN-08-3703

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Cellular UV damage responses--functions of tumor suppressor p53.

Authors:  Leena Latonen; Marikki Laiho
Journal:  Biochim Biophys Acta       Date:  2005-07-25

Review 2.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.

Authors:  Z L Chu; T A McKinsey; L Liu; J J Gentry; M H Malim; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

5.  Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J M O'Riordan; M M Abdel-latif; N Ravi; D McNamara; P J Byrne; G S A McDonald; P W N Keeling; D Kelleher; J V Reynolds
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

6.  Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus.

Authors:  N Katada; R A Hinder; T C Smyrk; N Hirabayashi; G Perdikis; R J Lund; T Woodward; P J Klingler
Journal:  Arch Surg       Date:  1997-07

7.  Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues.

Authors:  Katerina Dvorakova; Claire M Payne; Lois Ramsey; Harris Bernstein; Hana Holubec; Melissa Chavarria; Carol Bernstein; Richard E Sampliner; Chris Riley; Anil Prasad; Harinder Garewal
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

8.  Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus.

Authors:  N Rioux-Leclercq; B Turlin; F Sutherland; N Heresbach; B Launois; J P Campion; M P Ramee
Journal:  Oncol Rep       Date:  1999 Jul-Aug       Impact factor: 3.906

9.  Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.

Authors:  Rhonda F Souza; Kenneth L Shewmake; Yuenan Shen; Ruben D Ramirez; Jeff S Bullock; Christa L Hladik; Edward L Lee; Lance S Terada; Stuart J Spechler
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

10.  Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice.

Authors:  R H Whitehead; P E VanEeden; M D Noble; P Ataliotis; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  24 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

Review 2.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

3.  Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.

Authors:  Sumera Rizvi; Cathrine J Demars; Andrea Comba; Vladimir G Gainullin; Zaheer Rizvi; Luciana L Almada; Kenneth Wang; Gwen Lomberk; Martin E Fernández-Zapico; Navtej S Buttar
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.

Authors:  Cameron M Smith; David I Watson; Mary P Leong; George C Mayne; Michael Z Michael; Bas P L Wijnhoven; Damian J Hussey
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

5.  Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.

Authors:  Wibisono Hartojo; Amy L Silvers; Dafydd G Thomas; Christopher W Seder; Lin Lin; Hyma Rao; Zhuwen Wang; Joel K Greenson; Thomas J Giordano; Mark B Orringer; Alnawaz Rehemtulla; Mahaveer S Bhojani; David G Beer; Andrew C Chang
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

6.  Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.

Authors:  Romy E Verbeek; Peter D Siersema; Fiebo J Ten Kate; Kees Fluiter; Rhonda F Souza; Frank P Vleggaar; Pauline Bus; Jantine W P M van Baal
Journal:  J Gastroenterol       Date:  2013-08-17       Impact factor: 7.527

Review 7.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

Review 8.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.

Authors:  Hui Ying Zhang; Kathy Hormi-Carver; Xi Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

10.  A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model.

Authors:  Nicolas A Pardon; Maria Vicario; Hanne Vanheel; Tim Vanuytsel; Laurens J Ceulemans; Michael Vieth; Marcel Jimenez; Jan Tack; Ricard Farré
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-21       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.